Cannabinoid Research

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S. FDA approvals regarding its cannabinoid pharmaceutical products and psychedelic...

Canopy Growth Corp (NYSE: CGC) will be researching the efficacy of cannabinoids in treatment of post-concussion neurological diseases in partnership with the NHL Alumni Association and NEEKA Health Canada. What Happened The NHLAA and NEEKA Enterprises, a health care company, will work together to...